28
Participants
Start Date
December 31, 2003
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Celebrex
"Celebrex 200 mg PO BID for the first 8 weeks, followed by a 1 week washout period then placebo PO BID for the remaining 8 weeks - or - placebo PO BID for the first 8 weeks, followed by a 1 week washout period then Celebrex 200 mg PO BID for the remaining 8 weeks."
placebo
placebo PO BID for either the first eight weeks or the last eight weeks of the study.
Collaborators (1)
Shadyside Hospital Foundation
OTHER
Pfizer
INDUSTRY
University of Pittsburgh
OTHER